Avantor (NYSE:AVTR) Raised to “Strong Sell” at Wolfe Research

by · The Cerbat Gem

Avantor (NYSE:AVTR – Get Free Report) was upgraded by equities research analysts at Wolfe Research to a “strong sell” rating in a note issued to investors on Monday,Zacks.com reports.

Several other analysts also recently weighed in on AVTR. Royal Bank Of Canada started coverage on Avantor in a research note on Thursday, May 14th. They set a “sector perform” rating and a $9.00 target price for the company. Wells Fargo & Company reduced their price target on Avantor from $16.00 to $14.00 and set an “overweight” rating for the company in a report on Friday, February 13th. TD Cowen restated a “hold” rating on shares of Avantor in a report on Thursday, February 12th. Zacks Research upgraded Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, April 30th. Finally, UBS Group restated a “neutral” rating and issued a $10.50 price target on shares of Avantor in a research note on Thursday, February 12th. Two analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Reduce” and an average price target of $10.57.

Check Out Our Latest Research Report on AVTR

Avantor Stock Performance

Shares of NYSE AVTR opened at $9.10 on Monday. The company has a 50-day simple moving average of $8.11 and a 200-day simple moving average of $9.70. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17. The company has a market cap of $6.22 billion, a PE ratio of -11.24, a price-to-earnings-growth ratio of 5.21 and a beta of 0.97. Avantor has a 12 month low of $7.26 and a 12 month high of $15.93.

Avantor (NYSE:AVTR – Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.01. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. During the same period last year, the company earned $0.23 earnings per share. The company’s quarterly revenue was up .0% on a year-over-year basis. On average, equities analysts anticipate that Avantor will post 0.79 earnings per share for the current year.

Insiders Place Their Bets

In other Avantor news, Director Simon Dingemans acquired 25,000 shares of the firm’s stock in a transaction that occurred on Friday, May 1st. The stock was acquired at an average cost of $8.14 per share, with a total value of $203,500.00. Following the acquisition, the director directly owned 25,000 shares of the company’s stock, valued at $203,500. This represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Sanjeev K. Mehra bought 125,000 shares of the business’s stock in a transaction on Tuesday, March 10th. The shares were acquired at an average cost of $8.01 per share, for a total transaction of $1,001,250.00. Following the purchase, the director directly owned 475,000 shares in the company, valued at $3,804,750. This represents a 35.71% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders bought 160,000 shares of company stock worth $1,287,950. Insiders own 0.28% of the company’s stock.

Institutional Investors Weigh In On Avantor

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Royal Bank of Canada increased its holdings in shares of Avantor by 104.3% in the first quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock valued at $3,302,000 after buying an additional 104,022 shares in the last quarter. Empowered Funds LLC lifted its stake in Avantor by 40.3% during the first quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock valued at $286,000 after buying an additional 5,075 shares in the last quarter. Cetera Investment Advisers boosted its holdings in shares of Avantor by 40.2% in the second quarter. Cetera Investment Advisers now owns 40,289 shares of the company’s stock worth $542,000 after buying an additional 11,543 shares during the period. Quantbot Technologies LP purchased a new position in shares of Avantor in the second quarter worth approximately $232,000. Finally, Arrowstreet Capital Limited Partnership increased its position in shares of Avantor by 214.9% in the second quarter. Arrowstreet Capital Limited Partnership now owns 124,076 shares of the company’s stock worth $1,670,000 after acquiring an additional 84,679 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors.

Avantor Company Profile

(Get Free Report)

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.

Featured Stories